Methods 80 81

Study design and sample collection 82
The samples used in this study were generated during a larger randomised controlled trial 83 (ClinicalTrials.gov NCT02972957) comparing the impact of LAIV on the nasopharyngeal 84 microbiome. The trial was conducted in Sukuta, a periurban area in The Gambia during 2017 85 and 2018. A detailed description of the cohort and sampling is described elsewhere [3] . No significant differences were seen between pre-LAIV HAI titres to egg-cultured and cell-153 cultured HK14 (p=0.84, Figure S2 ). The proportion of children who seroconverted to egg-154 cultured HK14 virus was 25.0% (61/244, 95% confidence interval (CI) 19.6-30.4) compared 155 to 12.3% (30/244, 95% CI 8.2-16.4) to cell-cultured HK14 (p<0.0001). D0 to D21 GMFR to 156 egg-cultured HK14 was greater than to cell-cultured HK14 (p<0.0001, Figure 1A ). A 157 significant correlation was present between GMFR to egg-cultured and cell-cultured HK14 158 (rs=0.58, p<0.0001, Figure S3 ), although discrepant samples were observed with 159 seroconversion to only one virus ( Figure 1B) . In contrast, the increase in mucosal influenza 160 HA-specific IgA from D0 to D21 post-LAIV was greater to cell-culture matched HK14 HA 161 compared to egg-culture matched HK14 HA (p=0.0009, Figure 1C ). A significant correlation 162 was observed between IgA fold-change to egg-and cell-cultured HK14 HA (r=0.69, 163 p<0.0001, Figure S4 ). 164
165
To explore the impact of prior H3N2 infection on serum and mucosal antibody responses to 166 HK14 in LAIV, children were stratified based on seropositivity to cell-cultured HK14 (pre-167 LAIV HAI titre ³1:10). In seronegative children, seroconversion to egg-cultured HK14 (50.7%, 168 37/73, 95% CI 39.2-62.2%) and cell-cultured HK14 (27.4%, 20/73, 95% CI 17.2-37.6%) was 169 greater than in seropositive children (14.0% seroconversion to egg-cultured, 24/171, 95% CI 170 8.8-19.4%, p=0.00048 and 5.8% seroconversion to cell-cultured, 10/171, 95% CI 2.3-9.4%, 9 176 To explore whether reversion of egg-adapted mutations in LAIV HK14 during 177 nasopharyngeal replication could drive responses to cell-cultured HK14, we sequenced two 178 sub-amplicons containing HA amino-acids 1-276. 20 samples with low H3N2 cycle threshold 179 (Ct) values (five D2 and fifteen D7 from sixteen individuals) were successfully amplified 180 (Supplementary material, Figure S5 ). No significant reversion of egg-adaptive mutations was 181 seen in any samples ( Figure 2C ). This included D7 samples from seven seroconverters to cell-182 cultured HK14. Two samples showed a single sequence with P194L (<0.2% frequency) and 183 three samples showed one or two sequences with I203T (<0.2% frequency). Along with 184 position 160, these three sites were >99.9% identical to the vaccine across all samples. Few 185 mutations rose to high frequency with only five mutations occurring above 5%. Of these, 186
I23L was a pre-existing polymorphism present at 1% in the vaccine strain and the other four 187 mutations were synonymous. There was no significant difference between Shannon entropy 188 for the samples and vaccine strains (Z-test, p=0.41). In individuals with matched samples, 189 mutations present at higher frequencies on D2 had been lost by D7 ( Figure 2C influenza-specific IgA responses are more cross-reactive that IgG responses [9, 10] . It is 215 important to note that the IgA responses measured constitute binding antibody, rather than 216 functional responses, which are challenging to measure in mucosal samples. Future work 217 could explore functional mucosal IgA responses, as well as anti-HA stalk responses which we 218 did not assess and may provide cross-reactive responses. 219 220 A previous influenza human challenge study in adults has demonstrated the reversion of an 221 egg-adapted mutation during replication in the upper respiratory tract [11] . We 222 hypothesized that a similar phenomenon could occur with LAIV replication of HK14, 223 providing a potential explanation for cell-cultured HK14-specific antibody responses after 224 vaccination with an egg-adapted antigen. Sequencing of the shed virus, however, revealed 225 no changes at sites of egg adaptation and very few significant changes in the HA. The lack of 226 a K160 fitness cost in humans is perhaps unsurprising given the majority of H3N2 isolates 227 prior to 2014 contained K160. Recent studies have found low within-host diversity of virus 228 in natural influenza infections in vaccinated and unvaccinated individuals, suggesting that 229 the immune system does not put significant pressure on the influenza virus to evolve over 230
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